SecBot SecBot
PRESS-RELEASE ·Filed Nov 5, 2026

TMDX

TransMedics Group, Inc.
BULLISH
Impact 6/10
Horizonmonths Processed11d 11h ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ▲ Bullish

The raised guidance and strong Q3 beat, combined with FDA IDE approvals for ENHANCE Heart Part B and DENOVO Lung trials, signal accelerating commercial momentum and a clear pipeline catalyst path into 2027. Monitor enrollment progress in these trials and European expansion for further upside.

DirectionBullish
Confidencehigh
Horizonmonths

Price Chart

Loading chart...

Executive Summary

TransMedics reported Q3 2026 revenue of $203.0M (+41% YoY) and GAAP EPS of $0.46, beating consensus estimates of $177.1M and $0.29. The company raised full-year 2026 revenue guidance to $764-$774M (including PAD Aviation), up from prior guidance of $737-$757M, driven by record case volume and strong execution in the National OCS Program.

Key Financial Metrics

EPS
$0.46
est $0.29 · +58.6%
Revenue
$203.0M
est $177.1M · +14.6% · +41.0% YoY
Rating
strong beat
Guidance
$764M-$774M
raised
Gross Margin
58.5%

Key Facts

  • Q3 2026 total revenue $203.0M, up 41% YoY, beating $177.1M consensus
  • GAAP diluted EPS $0.46 vs consensus $0.29 (beat)
  • Adjusted diluted EPS $0.51
  • Full-year 2026 revenue guidance raised to $764-$774M (incl. PAD Aviation), up from $737-$757M
  • Product revenue $113.4M (+29% YoY), service revenue $89.6M (+60% YoY)
  • Net income $17.1M vs $24.3M in Q3 2025; GAAP EPS $0.46 vs $0.66 YoY
  • Cash $493.0M as of September 30, 2026
  • Completed enrollment in ENHANCE Heart Part A; received FDA IDE approvals for ENHANCE Heart Part B and DENOVO Lung trials
  • Awarded first European transplant logistics tender in Italy

Financial Impact

Revenue beat consensus by $25.9M (14.6%); EPS beat consensus by $0.17 (58.6%); full-year guidance raised by $27M at midpoint

revenueepsguidance

Segment Breakdown

SegmentRevenueGrowth
Product$113.4M+29.0%
Service$89.6M+60.0%

Risk Factors

  • GAAP EPS declined YoY ($0.46 vs $0.66) due to higher operating expenses and interest costs
  • Operating margin contracted 230bps YoY to 13.9%
  • Dependence on continued adoption of National OCS Program and regulatory approvals for new indications

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-prn-302931330

Track record

9 reports on TMDX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Entry $90.95 Now $92.21 +1.39% settles Nov 17
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
  3. Nov 5, 202611d ago Press Release Bullish 6/10 Viewing No price data
  4. Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
  5. Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
  6. Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
  7. Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
  8. Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
  9. Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 6h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026